Abstract: Method of treatment of ocular hypertension and glaucoma which comprises administering an effective amount of prostaglandin D.sub.2 -active substance to a subject in need of such treatment.
Type:
Grant
Filed:
May 4, 1987
Date of Patent:
April 25, 1989
Assignees:
Yasumasa Goh, Research Development Corporation of Japan